StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
631
This month
8
This week
3
This year
55
Today
1
Yesterday
1
Publishing Date
2024 - 03 - 25
3
2024 - 02 - 06
3
2024 - 01 - 08
3
2023 - 11 - 06
3
2023 - 10 - 16
3
2023 - 05 - 09
4
2023 - 03 - 13
3
2023 - 03 - 02
3
2023 - 02 - 07
3
2022 - 11 - 04
4
2022 - 11 - 02
3
2022 - 09 - 05
3
2022 - 06 - 20
3
2022 - 05 - 11
4
2022 - 05 - 03
6
2022 - 05 - 02
3
2022 - 04 - 05
3
2022 - 03 - 28
4
2022 - 03 - 24
4
2022 - 02 - 21
3
2022 - 01 - 04
3
2021 - 11 - 12
3
2021 - 11 - 09
4
2021 - 11 - 05
3
2021 - 09 - 15
2
2021 - 08 - 31
2
2021 - 08 - 30
3
2021 - 08 - 25
2
2021 - 08 - 16
2
2021 - 08 - 11
2
2021 - 08 - 09
2
2021 - 08 - 06
3
2021 - 08 - 04
2
2021 - 07 - 29
3
2021 - 07 - 22
2
2021 - 07 - 12
3
2021 - 07 - 09
2
2021 - 06 - 26
2
2021 - 06 - 22
2
2021 - 06 - 21
2
2021 - 06 - 16
3
2021 - 06 - 14
2
2021 - 06 - 09
2
2021 - 06 - 07
2
2021 - 05 - 28
3
2021 - 05 - 27
3
2021 - 05 - 25
3
2021 - 05 - 11
3
2021 - 05 - 07
3
2021 - 05 - 04
2
2021 - 04 - 21
2
2021 - 04 - 19
2
2021 - 04 - 13
2
2021 - 04 - 08
2
2021 - 03 - 29
2
2021 - 03 - 25
3
2021 - 03 - 18
4
2021 - 03 - 16
2
2021 - 03 - 15
2
2020 - 12 - 07
2
Sector
Commercial services
5
Communications
2
Consumer durables
2
Consumer non-durables
3
Consumer services
1
Distribution services
1
Electronic technology
5
Energy minerals
1
Finance
14
Finance and insurance
3
Health care and social assistance
1
Health services
4
Health technology
631
Manufacturing
17
N/a
7
Process industries
1
Producer manufacturing
1
Professional, scientific, and technical services
4
Retail trade
2
Technology services
4
Tags
Acquire
7
Agreement
5
Application
6
Approval
7
Biotech
7
Biotechnology
5
Bleeding
7
Blood
5
Cancer
5
Cardiovascular
5
Collaboration
8
Companies
6
Conference
20
Device
5
Diabetes
34
Disease
18
Drug
18
Earnings
8
Europe
10
Events
22
Expansion
7
Expected
10
Fda
11
Financial
7
Financial results
7
Genetown
7
Global
45
Growing
5
Growth
33
Hormone
7
Insulin
32
Iot
6
Kidney
5
Liver
11
Market
78
Money
7
N/a
516
Obesity
16
People
11
Pharma
81
Pharmaceutical
12
Phase 2
7
Phase 3
6
Program
10
Reach
9
Report
38
Repurchase
96
Research
34
Results
20
S
42
Sales
13
Sanofi
7
Study
6
Technology
10
Therapeutics
26
Therapy
11
Treatment
34
Trial
32
Trials
8
Update
12
Entities
89bio, inc.
2
Abbott laboratories
20
Abbvie inc.
14
Alnylam pharmaceuticals, inc.
25
Altimmune, inc.
2
Amazon.com, inc.
2
Amgen inc.
17
Astellas pharma inc
3
Astrazeneca plc
29
Bausch health companies inc.
2
Baxter international inc.
8
Becton, dickinson and company
12
Biogen inc.
7
Blackrock, inc.
5
Bnp paribas
3
Boston scientific corporation
3
Bristol-myers squibb company
7
Catalent, inc.
2
Charles river laboratories international, inc.
2
Csl ltd
3
Denali therapeutics inc.
2
Dexcom, inc.
3
Eiger biopharmaceuticals, inc.
2
Eli lilly and company
82
Endo international plc
5
Entera bio ltd.
2
Forma therapeutics holdings, inc.
2
Galectin therapeutics inc.
3
Genmab a/s
4
Gilead sciences, inc.
10
Glaukos corporation
2
Glaxosmithkline plc
26
Global blood therapeutics, inc.
2
Icon plc
5
Incannex healthcare ltd
2
Innate pharma s.a.
71
Innate pharma sa
44
Insulet corporation
11
Ionis pharmaceuticals, inc.
3
Iqvia holdings, inc.
2
Johnson & johnson
44
Kamada ltd.
2
Karyopharm therapeutics inc.
2
Lipocine inc.
3
Madrigal pharmaceuticals, inc.
3
Mallinckrodt plc
2
Medtronic plc
14
Novartis ag
28
Novo nordisk a/s
631
Pfizer, inc.
11
Regeneron pharmaceuticals, inc.
4
Retractable technologies, inc.
4
Sanofi
139
Takeda pharmaceutical company limited
15
Terumo corp
9
Teva pharmaceutical industries ltd
15
Thermo fisher scientific inc
4
Vertex pharmaceuticals incorporated
3
Viatris inc.
7
Zealand pharma a/s
9
Symbols
AAPL
1194
ABB
1423
ABBV
1023
ABLZF
1162
ABT
1784
ACN
600
AMGN
742
ARVL
4285
AZN
664
BDX
796
BMY
662
BNPQF
1764
BNPQY
1764
CSCO
895
DHR
785
ERIC
1608
F
641
FNCTF
7171
FRBA
595
GE
915
GLAXF
657
GOOG
1274
GOOGL
1273
GSK
883
HON
1779
HUBS
1400
IBM
654
INTC
954
IT
590
JNJ
4571
LLY
1708
LTUM
970
LYV
717
MDT
1285
MMM
938
MS
4279
MSFT
1199
MT
588
NOC
589
NOK
899
NOKBF
973
NVO
631
NVS
1241
NVSEF
1031
ORCL
1157
PCRFF
650
PCRFY
650
PFE
692
PHG
962
PPRUF
1126
PPRUY
1127
SAP
1474
SAPGF
1228
SNOW
794
SNY
4532
SNYNF
3590
TEVJF
630
TMO
1621
VZ
1211
XYF
674
Exchanges
Amex
5
Nasdaq
250
Nyse
631
Crawled Date
2024 - 03 - 25
3
2024 - 02 - 06
3
2024 - 01 - 08
3
2023 - 11 - 06
3
2023 - 10 - 16
3
2023 - 09 - 13
3
2023 - 05 - 09
4
2023 - 03 - 13
3
2023 - 03 - 02
3
2023 - 02 - 23
3
2023 - 02 - 07
3
2022 - 11 - 04
4
2022 - 11 - 02
3
2022 - 09 - 05
3
2022 - 06 - 20
3
2022 - 05 - 11
4
2022 - 05 - 03
6
2022 - 05 - 02
3
2022 - 04 - 05
3
2022 - 03 - 28
4
2022 - 03 - 24
4
2022 - 02 - 21
3
2022 - 01 - 04
3
2021 - 11 - 12
3
2021 - 11 - 09
4
2021 - 11 - 05
3
2021 - 08 - 30
3
2021 - 08 - 25
2
2021 - 08 - 16
2
2021 - 08 - 11
2
2021 - 08 - 09
2
2021 - 08 - 06
3
2021 - 08 - 04
2
2021 - 07 - 29
3
2021 - 07 - 22
2
2021 - 07 - 12
3
2021 - 07 - 09
2
2021 - 06 - 27
2
2021 - 06 - 22
2
2021 - 06 - 21
2
2021 - 06 - 16
3
2021 - 06 - 14
2
2021 - 06 - 09
2
2021 - 06 - 07
2
2021 - 05 - 28
3
2021 - 05 - 27
3
2021 - 05 - 25
3
2021 - 05 - 11
3
2021 - 05 - 07
3
2021 - 05 - 04
2
2021 - 04 - 21
2
2021 - 04 - 19
2
2021 - 04 - 13
2
2021 - 04 - 08
2
2021 - 03 - 29
2
2021 - 03 - 25
3
2021 - 03 - 18
4
2021 - 03 - 16
2
2021 - 03 - 15
2
2020 - 12 - 07
2
Crawled Time
00:00
4
00:20
3
01:00
7
02:00
6
03:00
1
04:00
3
04:20
5
05:00
5
06:00
33
07:00
36
07:04
1
08:00
31
09:00
15
10:00
29
11:00
35
11:33
1
12:00
65
12:15
9
12:20
16
12:30
10
13:00
37
13:15
7
13:20
9
13:30
9
14:00
38
14:05
1
14:15
3
14:20
6
14:30
5
15:00
38
15:01
1
15:15
2
15:20
8
15:30
8
16:00
24
16:20
2
17:00
23
17:01
1
18:00
19
19:00
14
20:00
16
20:20
1
21:00
19
21:06
1
22:00
16
23:00
8
Source
www.aspenpharma.com
1
www.biospace.com
112
www.globenewswire.com
342
www.prnewswire.com
176
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Nvo
save search
Novo Nordisk A/S - share repurchase programme
Published:
2024-01-30
(Crawled : 15:30)
- globenewswire.com
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
14.23%
|
O:
0.16%
H:
0.13%
C:
-0.16%
repurchase
Transthyretin Amyloidosis Market is Predicted to Exhibit Remarkable Growth by 2032, Predicts DelveInsight | Key Players - Attralus, Alnylam Pharmaceuticals, Ionis Pharmaceuticals, AstraZeneca, Alexion Pharmaceuticals, Novo Nordisk
Published:
2024-01-24
(Crawled : 23:00)
- prnewswire.com
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
18.36%
|
O:
0.49%
H:
0.0%
C:
-0.05%
IONS
|
$40.93
-1.47%
-1.49%
1.1M
|
Health Technology
|
-19.15%
|
O:
0.38%
H:
2.34%
C:
1.56%
key
growth
market
Elo Life Systems Announces Oversubscribed $20.5 Million Series A2 Funding Round
Published:
2024-01-24
(Crawled : 14:00)
- prnewswire.com
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
18.18%
|
O:
1.21%
H:
0.36%
C:
-1.35%
life
million
series
funding
Novo Nordisk A/S - share repurchase programme
Published:
2024-01-22
(Crawled : 12:00)
- globenewswire.com
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
16.43%
|
O:
-0.6%
H:
0.27%
C:
-0.78%
repurchase
Beta-thalassemia Market to Witness Upsurge in Growth During the Study Period (2019-2032), Evaluates DelveInsight | Leading Companies - Vertex Pharmaceuticals, CRISPR Therapeutics, Agios Pharmaceuticals, Celgene, Forma Therapeutics
Published:
2024-01-17
(Crawled : 22:00)
- prnewswire.com
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
16.73%
|
O:
-0.36%
H:
1.32%
C:
1.18%
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-9.67%
|
O:
-0.21%
H:
0.0%
C:
0.0%
VRTX
|
$393.1
-0.27%
-0.27%
880K
|
Health Technology
|
-9.37%
|
O:
-0.5%
H:
0.76%
C:
0.32%
EDIT
|
$5.615
-4.02%
-4.19%
1.9M
|
Health Technology
|
-30.44%
|
O:
0.83%
H:
0.35%
C:
-3.66%
AGIO
|
$29.03
0.8%
0.79%
500K
|
Health Technology
|
32.66%
|
O:
0.41%
H:
0.0%
C:
-2.2%
crispr
companies
therapeutics
growth
study
market
Cleveland Diagnostics Completes $75M Financing to Advance its Early-detection Oncology Testing Platform
Published:
2024-01-17
(Crawled : 14:30)
- biospace.com/
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
17.09%
|
O:
-0.03%
H:
0.75%
C:
0.34%
diagnostics
platform
Novo Nordisk A/S - share repurchase programme
Published:
2024-01-15
(Crawled : 11:00)
- globenewswire.com
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
Email alert
Add to watchlist
repurchase
Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companies - ACELYRIN, Genentech, ChemoCentryx, Travere Therapeutics, Boehringer Ingelheim, Chinook Therapeutics
Published:
2024-01-10
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-10.95%
|
O:
1.1%
H:
0.0%
C:
0.0%
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
14.59%
|
O:
-0.33%
H:
0.35%
C:
-1.5%
LLY
|
News
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
19.13%
|
O:
0.67%
H:
0.85%
C:
0.21%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-11.29%
|
O:
0.69%
H:
0.0%
C:
0.0%
ALDX
4
|
$3.98
2.84%
2.76%
640K
|
Health Technology
|
15.87%
|
O:
-1.8%
H:
0.46%
C:
-2.44%
companies
therapeutics
growth
market
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published:
2024-01-09
(Crawled : 16:00)
- globenewswire.com
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
17.04%
|
O:
-0.25%
H:
0.79%
C:
0.77%
Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs
Published:
2024-01-08
(Crawled : 13:30)
- prnewswire.com
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
-0.26%
|
O:
2.71%
H:
0.36%
C:
0.11%
LEXX
|
$2.33
0.87%
0.86%
460K
|
Health Technology
|
73.33%
|
O:
0.0%
H:
8.15%
C:
1.48%
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-13.74%
|
O:
-0.37%
H:
1.09%
C:
0.75%
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
17.5%
|
O:
0.19%
H:
0.34%
C:
0.21%
MRK
|
$125.37
0.25%
0.1%
6.1M
|
Health Technology
|
6.95%
|
O:
0.32%
H:
0.26%
C:
-0.18%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
-0.17%
|
O:
0.28%
H:
0.99%
C:
0.93%
COMBINE 3 phase 3a trial successfully completed with once-weekly IcoSema demonstrating non-inferior reduction in HbA1c versus daily basal-bolus treatment (insulin glargine U100 and insulin aspart) in people with type 2 diabetes
Published:
2024-01-08
(Crawled : 13:00)
- globenewswire.com
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
17.5%
|
O:
0.19%
H:
0.34%
C:
0.21%
treatment
glargine
trial
diabetes
insulin
Novo Nordisk A/S - share repurchase programme
Published:
2024-01-08
(Crawled : 11:00)
- globenewswire.com
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
17.5%
|
O:
0.19%
H:
0.34%
C:
0.21%
repurchase
Novo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel treatment approaches for cardiometabolic diseases
Published:
2024-01-04
(Crawled : 11:00)
- globenewswire.com
OMGA
|
$2.565
6.43%
6.04%
390K
|
|
-6.23%
|
O:
92.31%
H:
20.0%
C:
1.24%
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
20.18%
|
O:
1.44%
H:
3.68%
C:
2.4%
treatment
research
therapeutics
2023 Novo Holdings Seed Investments Team Annual Review/Business Update
Published:
2024-01-04
(Crawled : 08:00)
- prnewswire.com
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
20.18%
|
O:
1.44%
H:
3.68%
C:
2.4%
investments
update
Nalu Medical, Inc. Announces $65 Million Equity Financing to Advance Treatment for Chronic Neuropathic Pain
Published:
2024-01-03
(Crawled : 17:00)
- biospace.com/
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
21.96%
|
O:
-0.06%
H:
1.75%
C:
1.54%
million
treatment
Biologics Global Market Forecast Report 2024-2034 - Challenges Posed by Patent Expiration for Biologics
Published:
2023-12-22
(Crawled : 17:00)
- prnewswire.com
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-3.25%
|
O:
3.66%
H:
0.0%
C:
-0.12%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
3.68%
|
O:
3.33%
H:
0.0%
C:
-2.93%
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
20.34%
|
O:
-0.31%
H:
0.39%
C:
-0.44%
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-5.7%
|
O:
1.09%
H:
0.0%
C:
0.0%
LLY
|
News
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
31.25%
|
O:
0.18%
H:
0.5%
C:
-0.46%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-5.85%
|
O:
-0.78%
H:
5.15%
C:
2.81%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
7.64%
|
O:
0.58%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-5.38%
|
O:
1.03%
H:
0.0%
C:
0.0%
REGN
|
$901.27
0.8%
0.78%
470K
|
Health Technology
|
7.04%
|
O:
0.52%
H:
0.58%
C:
0.05%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-15.2%
|
O:
0.34%
H:
1.02%
C:
0.59%
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
-23.13%
|
O:
0.57%
H:
1.36%
C:
1.04%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
2.96%
|
O:
1.06%
H:
0.18%
C:
-1.06%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
-4.44%
|
O:
0.24%
H:
2.03%
C:
1.49%
patent
report
global
market
Novo Nordisk A/S - share repurchase programme
Published:
2023-12-22
(Crawled : 12:00)
- globenewswire.com
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
20.34%
|
O:
-0.31%
H:
0.39%
C:
-0.44%
repurchase
Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published:
2023-12-19
(Crawled : 08:00)
- biospace.com/
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
25.81%
|
O:
0.91%
H:
0.72%
C:
0.11%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-4.83%
|
O:
0.45%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
-9.27%
-10.21%
16K
|
Health Technology
|
-1.63%
|
O:
13.88%
H:
0.0%
C:
-3.58%
pharma
natural
cell
sanofi
Novo Nordisk A/S - share repurchase programme
Published:
2023-12-18
(Crawled : 13:30)
- globenewswire.com
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
28.25%
|
O:
2.49%
H:
0.28%
C:
-0.54%
repurchase
Incretin-based Drugs Market to Reach $73.9 billion, globally, by 2032 at 7.9% CAGR: Allied Market Research
Published:
2023-12-15
(Crawled : 15:30)
- prnewswire.com
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
2.12%
|
O:
-3.0%
H:
2.15%
C:
2.15%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.45%
|
O:
0.0%
H:
0.0%
C:
0.0%
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
27.07%
|
O:
-0.48%
H:
0.0%
C:
-0.44%
NVS
|
News
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-5.86%
|
O:
-1.31%
H:
0.56%
C:
-0.17%
LLY
|
News
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
26.46%
|
O:
-4.44%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-4.53%
|
O:
-0.93%
H:
0.0%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
2.89%
|
O:
-2.23%
H:
0.28%
C:
-0.11%
reach
research
market
← Previous
1
2
3
4
5
6
7
8
9
…
31
32
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.